Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state
- PMID: 18294829
- DOI: 10.1016/j.ejpb.2007.12.020
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state
Abstract
The influence of droplet size on the absorption from lipid and surfactant based formulations was evaluated from two self-emulsifying formulations, a surfactant solution, and an oil solution. The self-emulsifying formulations was a self-emulsifying (SEDDS) and a self-nanoemulsifying (SNEDDS) formulation containing equal lipid and surfactant load, but exhibiting a large difference (approx 100 times) in the mean particle diameter of the resultant emulsion. The formulations were evaluated in a bioavailability study in fasted and fed Göttingen minipigs using probucol as model drug. In order to determine the bioavailability, an oil-in-water emulsion was included as i.v. formulation. The fasted group was fasted overnight and offered the first daily meal approx 4 h after treatment. The fed group was offered the first daily meal (50% energy from fat) 30 min prior to treatment. In the fasted group the SNEDDS exhibited a slightly faster absorption and higher bioavailability than the SEDDS, though non-significant. Furthermore, the bioavailability from the surfactant solution and the oil solution were slightly lower compared to the SNEDDS, indicating that both small particle size and digestibility are important in ensuring optimal bioavailability. Comparing the absorption in fasted and fed minipigs showed that probucol exhibited no significant food effect, when formulated in a lipid and surfactant based formulations.
Similar articles
-
In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.Eur J Pharm Biopharm. 2008 Aug;69(3):887-98. doi: 10.1016/j.ejpb.2008.01.022. Epub 2008 Feb 1. Eur J Pharm Biopharm. 2008. PMID: 18367386
-
Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state.Eur J Pharm Sci. 2007 May;31(1):8-15. doi: 10.1016/j.ejps.2007.01.007. Epub 2007 Feb 3. Eur J Pharm Sci. 2007. PMID: 17383165
-
Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.Int J Pharm. 2009 Jun 5;374(1-2):66-72. doi: 10.1016/j.ijpharm.2009.03.008. Epub 2009 Mar 19. Int J Pharm. 2009. PMID: 19446761
-
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.Biomed Pharmacother. 2004 Apr;58(3):173-82. doi: 10.1016/j.biopha.2004.02.001. Biomed Pharmacother. 2004. PMID: 15082340 Review.
-
Enhancing intestinal drug solubilisation using lipid-based delivery systems.Adv Drug Deliv Rev. 2008 Mar 17;60(6):673-91. doi: 10.1016/j.addr.2007.10.014. Epub 2007 Nov 7. Adv Drug Deliv Rev. 2008. PMID: 18155801 Review.
Cited by
-
Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol.Pharm Res. 2013 Dec;30(12):3029-44. doi: 10.1007/s11095-013-1063-y. Epub 2013 May 18. Pharm Res. 2013. PMID: 23686373
-
Characterising lipid lipolysis and its implication in lipid-based formulation development.AAPS J. 2012 Dec;14(4):860-71. doi: 10.1208/s12248-012-9398-6. Epub 2012 Sep 7. AAPS J. 2012. PMID: 22956477 Free PMC article. Review.
-
The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study.Pharm Res. 2011 Jul;28(7):1540-51. doi: 10.1007/s11095-011-0387-8. Epub 2011 Feb 24. Pharm Res. 2011. PMID: 21347568
-
Quality-by-Design-Based Development of a Voxelotor Self-Nanoemulsifying Drug-Delivery System with Improved Biopharmaceutical Attributes.Pharmaceutics. 2021 Sep 2;13(9):1388. doi: 10.3390/pharmaceutics13091388. Pharmaceutics. 2021. PMID: 34575467 Free PMC article.
-
Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations.AAPS J. 2017 Mar;19(2):587-594. doi: 10.1208/s12248-016-0038-4. Epub 2017 Jan 9. AAPS J. 2017. PMID: 28070714
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources